Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Vaccinia virus(VACV) H3L/Ag35 Antibody (B9)

Catalog #:   RVV13801 Specific References (26) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, Neutralization
Overview

Catalog No.

RVV13801

Species reactivity

Vaccinia virus(VACV)

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Envelope protein H3, Ag35, Virion envelope protein p35, H3L

Concentration

1.96 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

B9

Data Image
  • SDS-PAGE
    SDS PAGE for Anti-Vaccinia H3L/Ag35 Antibody (B9)
References

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development., PMID:39994775

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART II: Insights into the advancements in vaccines., PMID:39417768

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus., PMID:39321566

Expression of F1L, a vaccinia virus H3L transmembrane protein analogue of orf virus, and its successful purification as a diagnostic antigen., PMID:39136814

Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity., PMID:37300753

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens., PMID:36687315

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization., PMID:35746695

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses., PMID:33675226

Molecular Modelling and Insilico Engineering of PapMV-CP Towards Display and Development of Capripox Viral Like Particles Based on Immunogenic P32 Envelop Protein is the Homologous of the Vaccinia-Viral H3L Gene: An Insilico Approach., PMID:32421016

Phage display antibodies against ectromelia virus that neutralize variola virus: Selection and implementation for p35 neutralizing epitope mapping., PMID:29427674

Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models., PMID:28259752

Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models., PMID:26723250

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies., PMID:23133652

Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs., PMID:22100890

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model., PMID:20587859

Attenuation of vaccinia virus by the expression of human Flt3 ligand., PMID:20504356

An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling., PMID:18480455

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine., PMID:18234801

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice., PMID:16140750

Heparin binding activity of orf virus F1L protein., PMID:15351483

Identification and characterization of three immunodominant structural proteins of fowlpox virus., PMID:12208962

Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail., PMID:10906204

Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure., PMID:10729126

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo., PMID:10708453

A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene., PMID:10485266

The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein., PMID:9930187

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Vaccinia virus(VACV) H3L/Ag35 Antibody (B9) [RVV13801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only